Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Association of preoperative monocyte-to-lymphocyte and neutrophil-to-lymphocyte ratio with recurrence-free and overall survival after resection of pancreatic neuroendocrine tumors (US-NETSG).

Panni RZ, Lopez-Aguiar AG, Liu J, Poultsides GA, Rocha FG, Hawkins WG, Strasberg SM, Trikalinos NA, Maithel S, Fields RC; and other members of US-NETSG.

J Surg Oncol. 2019 Sep;120(4):632-638. doi: 10.1002/jso.25629. Epub 2019 Jul 24.

PMID:
31339198
2.

Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies.

Panni RZ, Herndon JM, Zuo C, Hegde S, Hogg GD, Knolhoff BL, Breden MA, Li X, Krisnawan VE, Khan SQ, Schwarz JK, Rogers BE, Fields RC, Hawkins WG, Gupta V, DeNardo DG.

Sci Transl Med. 2019 Jul 3;11(499). pii: eaau9240. doi: 10.1126/scitranslmed.aau9240.

PMID:
31270275
3.

National Pancreatic Fistula Rates after Minimally Invasive Pancreaticoduodenectomy: A NSQIP Analysis.

Panni RZ, Guerra J, Hawkins WG, Hall BL, Asbun HJ, Sanford DE.

J Am Coll Surg. 2019 Aug;229(2):192-199.e1. doi: 10.1016/j.jamcollsurg.2019.02.042. Epub 2019 Feb 21.

PMID:
30797082
4.

Predictive Value of Chromogranin A and a Pre-Operative Risk Score to Predict Recurrence After Resection of Pancreatic Neuroendocrine Tumors.

Fisher AV, Lopez-Aguiar AG, Rendell VR, Pokrzywa C, Rocha FG, Kanji ZS, Poultsides GA, Makris EA, Dillhoff ME, Beal EW, Fields RC, Panni RZ, Idrees K, Smith PM, Cho CS, Beems MV, Maithel SK, Winslow ER, Abbott DE, Weber SM.

J Gastrointest Surg. 2019 Apr;23(4):651-658. doi: 10.1007/s11605-018-04080-1. Epub 2019 Jan 18.

PMID:
30659439
5.

Social Belonging as a Predictor of Surgical Resident Well-being and Attrition.

Salles A, Wright RC, Milam L, Panni RZ, Liebert CA, Lau JN, Lin DT, Mueller CM.

J Surg Educ. 2019 Mar - Apr;76(2):370-377. doi: 10.1016/j.jsurg.2018.08.022. Epub 2018 Sep 19.

PMID:
30243929
6.

Recruitment of CCR2+ tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer.

Grossman JG, Nywening TM, Belt BA, Panni RZ, Krasnick BA, DeNardo DG, Hawkins WG, Goedegebuure SP, Linehan DC, Fields RC.

Oncoimmunology. 2018 Aug 1;7(9):e1470729. doi: 10.1080/2162402X.2018.1470729. eCollection 2018.

7.

Residual Tumor Index: A Prognostically Significant Pathologic Parameter in Neoadjuvant-treated Pancreatic Ductal Adenocarcinoma.

Panni RZ, Gonzalez I, Hartley CP, Williams GA, Liu J, Hawkins WG, Chatterjee D.

Am J Surg Pathol. 2018 Nov;42(11):1480-1487. doi: 10.1097/PAS.0000000000001144.

PMID:
30179901
8.

Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance.

Meyer MA, Baer JM, Knolhoff BL, Nywening TM, Panni RZ, Su X, Weilbaecher KN, Hawkins WG, Ma C, Fields RC, Linehan DC, Challen GA, Faccio R, Aft RL, DeNardo DG.

Nat Commun. 2018 Mar 28;9(1):1250. doi: 10.1038/s41467-018-03600-6.

9.

Intestinal resection-associated metabolic syndrome.

Barron L, Courtney C, Bao J, Onufer E, Panni RZ, Aladegbami B, Warner BW.

J Pediatr Surg. 2018 Jun;53(6):1142-1147. doi: 10.1016/j.jpedsurg.2018.02.077. Epub 2018 Mar 7.

10.

Comparative effectiveness of upfront esophagectomy versus induction chemoradiation in clinical stage T2N0 esophageal cancer: A decision analysis.

Semenkovich TR, Panni RZ, Hudson JL, Thomas T, Elmore LC, Chang SH, Meyers BF, Kozower BD, Puri V.

J Thorac Cardiovasc Surg. 2018 May;155(5):2221-2230.e1. doi: 10.1016/j.jtcvs.2018.01.006. Epub 2018 Jan 12.

11.

Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma.

Nywening TM, Belt BA, Cullinan DR, Panni RZ, Han BJ, Sanford DE, Jacobs RC, Ye J, Patel AA, Gillanders WE, Fields RC, DeNardo DG, Hawkins WG, Goedegebuure P, Linehan DC.

Gut. 2018 Jun;67(6):1112-1123. doi: 10.1136/gutjnl-2017-313738. Epub 2017 Dec 1.

12.

Preoperative predictors of conversion as indicators of local inflammation in acute cholecystitis: strategies for future studies to develop quantitative predictors.

Panni RZ, Strasberg SM.

J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):101-108. doi: 10.1002/jhbp.493. Epub 2017 Sep 9. Review.

13.

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial.

Nywening TM, Wang-Gillam A, Sanford DE, Belt BA, Panni RZ, Cusworth BM, Toriola AT, Nieman RK, Worley LA, Yano M, Fowler KJ, Lockhart AC, Suresh R, Tan BR, Lim KH, Fields RC, Strasberg SM, Hawkins WG, DeNardo DG, Goedegebuure SP, Linehan DC.

Lancet Oncol. 2016 May;17(5):651-62. doi: 10.1016/S1470-2045(16)00078-4. Epub 2016 Apr 4.

14.

Standardizing a control group for comparing open with laparoscopic major liver resection in observational studies: reducing the need for correction of clinical heterogeneity.

Panni RZ, Hall BL, Chapman WC, Strasberg SM.

J Am Coll Surg. 2014 Dec;219(6):1124-33. doi: 10.1016/j.jamcollsurg.2014.08.010. Epub 2014 Sep 10.

PMID:
25442067
15.

Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer.

Panni RZ, Sanford DE, Belt BA, Mitchem JB, Worley LA, Goetz BD, Mukherjee P, Wang-Gillam A, Link DC, Denardo DG, Goedegebuure SP, Linehan DC.

Cancer Immunol Immunother. 2014 May;63(5):513-28. doi: 10.1007/s00262-014-1527-x. Epub 2014 Mar 21.

16.

A Study of Zoledronic Acid as Neo-Adjuvant, Perioperative Therapy in Patients with Resectable Pancreatic Ductal Adenocarcinoma.

Sanford DE, Porembka MR, Panni RZ, Mitchem JB, Belt BA, Plambeck-Suess SM, Lin G, Denardo DG, Fields RC, Hawkins WG, Strasberg SM, Lockhart AC, Wang-Gillam A, Goedegebuure SP, Linehan DC.

J Cancer Ther. 2013 May;4(3):797-803.

17.

Targeting tumor-infiltrating macrophages to combat cancer.

Panni RZ, Linehan DC, DeNardo DG.

Immunotherapy. 2013 Oct;5(10):1075-87. doi: 10.2217/imt.13.102. Review.

18.

Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis.

Sanford DE, Belt BA, Panni RZ, Mayer A, Deshpande AD, Carpenter D, Mitchem JB, Plambeck-Suess SM, Worley LA, Goetz BD, Wang-Gillam A, Eberlein TJ, Denardo DG, Goedegebuure SP, Linehan DC.

Clin Cancer Res. 2013 Jul 1;19(13):3404-15. doi: 10.1158/1078-0432.CCR-13-0525. Epub 2013 May 7.

19.

Tumor-infiltrating macrophages, cancer stem cells and therapeutic responses.

Panni RZ, Linehan DC, Denardo DG.

Oncotarget. 2012 Dec;3(12):1497-8. No abstract available.

20.

Incidental finding of a giant aortic root aneurysm and its repair.

Fatimi SH, Panni RZ, Ashfaq A.

J Pak Med Assoc. 2012 Jun;62(6):617-9.

21.

Earlier surgical intervention in congenital heart disease results in better outcome and resource utilization.

Panni RZ, Ashfaq A, Amanullah MM.

BMC Health Serv Res. 2011 Dec 29;11:353. doi: 10.1186/1472-6963-11-353.

Supplemental Content

Loading ...
Support Center